✦ LIBER ✦

Tiotropium does not affect lower urinary tract functions in COPD patients with benign prostatic hyperplasia

✍ Scribed by Hiroo Miyazaki; Takafumi Suda; Atsushi Otsuka; Masao Nagata; Seiichiro Ozono; Dai Hashimoto; Yutaro Nakamura; Naoki Inui; Hirotoshi Nakamura; Kingo Chida

Book ID: 116853440
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 196 KB
Volume: 21
Category: Article
ISSN: 1094-5539
DOI: 10.1016/j.pupt.2008.10.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Baseline prostate specific antigen does

Baseline prostate specific antigen does not affect the efficacy of tamsulosin in patients with lower urinary tract symptoms/benign prostatic hyperplasia

✍ M.J. Speakman; J.R. Snijder; G.L. Anthonijs; C.A. Doyle 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 212 KB

MP-09.14: Does sildenafil affect the uro

MP-09.14: Does sildenafil affect the uroflowmetry values in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia?

✍ E. Tüzel; C. Güler; E. Doðantekin; G. Kýzýltepe 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 89 KB

Early efficacy of silodosin in patients

Early efficacy of silodosin in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia

✍ Tetsuya Takao; Akira Tsujimura; Hiroshi Kiuchi; Yasuhiro Matsuoka; Yasushi Miyag 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 263 KB

Tamsulosin is effective in patients with

Tamsulosin is effective in patients with lower urinary tract symptoms/benign prostatic hyperplasia, irrespective of prostate size

✍ M.J. Speakman; J.R. Snijder; G.L. Anthonijs; C.A. Doyle; A. Carter 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 198 KB

Effect of diabetes mellitus on lower uri

Effect of diabetes mellitus on lower urinary tract symptoms and dysfunction in patients with benign prostatic hyperplasia

✍ Tom A. Boon; Ger E. P. M. van Venrooij; Mardy D. Eckhardt 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 246 KB

Activity of phosphodiesterase type 5 inh

Activity of phosphodiesterase type 5 inhibitors in patients with lower urinary tract symptoms due to benign prostatic hyperplasia

✍ Chen Zhao; Suhn Hee Kim; Sung Won Lee; Ju-Hong Jeon; Kyung Ku Kang; Sung Beom Ch 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 287 KB